カテゴリ： MarketLine, カナダ, 企業調査

Goldcorp Inc：企業の戦略・SWOT・財務情報

◆英語タイトル：Goldcorp Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15582
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：57
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：カナダ
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Goldcorp Inc – Strategy, SWOT and Corporate Finance Report
Summary

Goldcorp Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Goldcorp Inc (Goldcorp) is a gold mining company. It is engaged in the exploration, development, extraction, processing, reclamation and acquisition of precious metal properties in Canada, the US, the Dominican Republic, Mexico, and Central and South America. Its product portfolio includes gold, silver, copper, lead and zinc. It also offers services which include acquisition and development of mineral properties and extraction and processing of minerals. The company operates through various mines, including Penasquito, Pueblo Viejo, Cerro Negro, Eleonore, Porcupine, Musselwhite and Red Lake. Moreover, it also owns several development projects such as Borden, HG Young, Norte Abierto JV, Century, Nueva Union JV, Coffee and Cochenour. Goldcorp is headquartered in Vancouver, British Columbia, Canada.

Scope

- Detailed information on Goldcorp Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Goldcorp Inc in the form of a SWOT analysis
- An in-depth view of the business model of Goldcorp Inc including a breakdown and examination of key business segments
- Intelligence on Goldcorp Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Goldcorp Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Goldcorp Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Goldcorp Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Goldcorp Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Goldcorp Inc: Company Overview
Goldcorp Inc: Overview and Key Facts
Goldcorp Inc: Overview
Goldcorp Inc: Key Facts
Goldcorp Inc: Key Employees
Goldcorp Inc: Key Employee Biographies
Goldcorp Inc: Major Products and Services
Goldcorp Inc: Company History
Goldcorp Inc: Management Statement
Goldcorp Inc: Locations and Subsidiaries
Goldcorp Inc: Key Competitors
Goldcorp Inc: Company Analysis
Goldcorp Inc: Business Description
Goldcorp Inc: SWOT Analysis
Goldcorp Inc: SWOT Overview
Goldcorp Inc: Strengths
Goldcorp Inc: Weaknesses
Goldcorp Inc: Opportunities
Goldcorp Inc: Threats
Goldcorp Inc: Corporate Financial Deals Activity
Goldcorp Inc: Financial Deals Overview
Goldcorp Inc: Targets and Partners
Goldcorp Inc: Top Deals 2015 – 2019YTD*
Goldcorp Inc: Advisors
Goldcorp Inc: Top Legal Advisors
Goldcorp Inc: Top Financial Advisors
Goldcorp Inc: Mergers and Acquisitions
Goldcorp Inc: Corporate Venturing
Goldcorp Inc: Partnership
Goldcorp Inc: Divestments
Goldcorp Inc: Private Equity and Ownership
Goldcorp Inc: Recent Developments
Goldcorp Inc: News and Events Summary
Goldcorp Inc: Contracts
Goldcorp Inc: Corporate Governance
Goldcorp Inc: Financial Deals
Goldcorp Inc: Financial Performance
Goldcorp Inc: Regulatory and Legal Events
Goldcorp Inc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Goldcorp Inc: Key Facts
Table 2: Goldcorp Inc: Key Employees
Table 3: Goldcorp Inc: Company History
Table 4: Goldcorp Inc: Locations and Subsidiaries
Table 5: Goldcorp Inc: Key Competitors
Table 6: Goldcorp Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Goldcorp Inc: M&A Activity by Geography (TTM*)
Table 8: Goldcorp Inc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: Goldcorp Inc: M&A Average Deal Size - Value (US$m)
Table 10: Goldcorp Inc: Targets and Partners
Table 11: Goldcorp Inc: Top Deals 2015 - 2019YTD*
Table 12: Goldcorp Inc: Legal Advisor Ranking by Value (US$m)
Table 13: Goldcorp Inc: Financial Advisor Ranking by Value (US$m)
Table 14: Goldcorp Inc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: Goldcorp Inc: M&A Activity by Geography (2015 - YTD*2019)
Table 16: Goldcorp Inc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: Goldcorp Inc: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: Goldcorp Inc: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 19: Goldcorp Inc: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 20: Goldcorp Inc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 21: Goldcorp Inc: Divestments by Geography (2015 - YTD*2019)
Table 22: Goldcorp Inc: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 23: Goldcorp Inc: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 24: Goldcorp Inc: News and Events Summary
Table 25: Goldcorp Inc: Contracts
Table 26: Goldcorp Inc: Corporate Governance
Table 27: Goldcorp Inc: Financial Deals
Table 28: Goldcorp Inc: Financial Performance
Table 29: Goldcorp Inc: Regulatory and Legal Events
Table 30: Goldcorp Inc: Strategy and Operations

List of Figures
Figure 1: Goldcorp Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Goldcorp Inc: M&A Activity by Geography (TTM*)
Figure 3: Goldcorp Inc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: Goldcorp Inc: M&A Average Deal Size - Value (US$m)
Figure 5: Goldcorp Inc: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: Goldcorp Inc: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: Goldcorp Inc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: Goldcorp Inc: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 9: Goldcorp Inc: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 10: Goldcorp Inc: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 11: Goldcorp Inc: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 12: Goldcorp Inc: Divestments by Geography (2015 - YTD*2019)
Figure 13: Goldcorp Inc: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Figure 14: Goldcorp Inc: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Goldcorp Inc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Avivagen Inc (VIV)：企業の財務・戦略的SWOT分析
    Summary Avivagen Inc (Avivagen), is a biotechnology company that provides drug development and animal healthcare products. It offers OxC-beta an active ingredient used to support the innate immune system and a healthy inflammatory condition of living beings. Avivagen's oxidized carotenoids promote a …
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675)：製薬・医療：M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • SRS Medical Systems Inc：医療機器：M&Aディール及び事業提携情報
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables products c …
  • Silmag SA：企業の製品パイプライン分析2018
    Summary Silmag SA (Silmag) is a manufacturer of biomedical products. The company offers products for vascular access, drainage, digestive tract, airway and urinary system. Its products include catheters, drainage tube, occlusion and identification tape, airway tube, double pigtail ureteral stent, cl …
  • Chaparral Energy Inc (CHPE)：石油・ガス：M&Aディール及び事業提携情報
    Summary Chaparral Energy Inc (Chaparral Energy) is an oil and gas company that produces crude oil and natural gas. The company’s business activities include exploration, development, production and operation of oil and gas properties and wells in America’s Midwest and Southwest regions. Its new oil …
  • Oxford Nanopore Technologies Ltd-医療機器分野：企業M&A・提携分析
    Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., is a biotechnology diagnostic company. It develops technologies for molecular detection and analysis. The company offers a range of nanopores and devices such as MinION, PromethION and GridION used for the ana …
  • Satair A/S：企業の戦略・SWOT・財務情報
    Satair A/S - Strategy, SWOT and Corporate Finance Report Summary Satair A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Shield Therapeutics Plc (STX)：企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Epiroc AB (EPI A)：企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chori Co Ltd (8014)：企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BrightPath Biotherapeutics Co Ltd (4594)：製薬・医療：M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Targa Resources Partners LP (NGLS PR A)-エネルギー分野：企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • PG&E Corporation：企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Catalina Holdings (Bermuda) Ltd：企業のM&A・事業提携・投資動向
    Catalina Holdings (Bermuda) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalina Holdings (Bermuda) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Mississippi Power Co：企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hindustan Petroleum Corp Ltd (HINDPETRO)：企業の財務・戦略的SWOT分析
    Hindustan Petroleum Corp Ltd (HINDPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • MicuRx Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …
  • ASML Holding N.V.：企業の戦略・SWOT・財務分析
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Taisho Pharmaceutical Co Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • DNAtrix Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆